Drug class
Vasoprotective agent; calcium dobesilate active anion
Mechanism of action
Reduces capillary permeability and fragility and may improve microvascular blood rheology and endothelial function. Its pharmacology is associated with modulation of vascular basement-membrane and inflammatory processes; the full molecular mechanism is not completely defined. Calcium is a counter-ion in calcium dobesilate.
General use cases
- Symptomatic treatment of chronic venous insufficiency and associated lower-limb symptoms in countries where authorised
- Some country-specific product information includes diabetic retinopathy or haemorrhoidal symptoms; verify the current local label before assigning these uses
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
